X-110451531-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001385449.1(RTL9):c.914G>A(p.Gly305Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000146 in 1,098,184 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001385449.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RTL9 | NM_001385449.1 | c.914G>A | p.Gly305Glu | missense_variant | 3/4 | ENST00000520821.6 | NP_001372378.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RTL9 | ENST00000520821.6 | c.914G>A | p.Gly305Glu | missense_variant | 3/4 | 4 | NM_001385449.1 | ENSP00000430395 | P1 | |
RTL9 | ENST00000465301.2 | c.914G>A | p.Gly305Glu | missense_variant | 3/4 | 1 | ENSP00000419786 | P1 | ||
RTL9 | ENST00000540313.1 | c.914G>A | p.Gly305Glu | missense_variant | 1/2 | 2 | ENSP00000441452 | P1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 exomes AF: 0.0000436 AC: 8AN: 183419Hom.: 0 AF XY: 0.0000295 AC XY: 2AN XY: 67859
GnomAD4 exome AF: 0.0000146 AC: 16AN: 1098184Hom.: 0 Cov.: 33 AF XY: 0.00000825 AC XY: 3AN XY: 363538
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2022 | The c.914G>A (p.G305E) alteration is located in exon 3 (coding exon 1) of the RGAG1 gene. This alteration results from a G to A substitution at nucleotide position 914, causing the glycine (G) at amino acid position 305 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at